(Q31137356)

18 August 2017

Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes (English)

1 reference

18 August 2017

1 reference

4

0 references

Jonatan Ising Bagger

object named as

Jonatan I Bagger

series ordinal

2

0 references

Tina Vilsbøll

series ordinal

6

object named as

Tina Vilsbøll

1 reference

18 August 2017

3

Ele Ferrannini

1 reference

18 August 2017

5

Filip K Knop

1 reference

18 August 2017

Andrea Mari

1

1 reference

PMC publication ID

3760909

18 August 2017

language of work or name

English

0 references

publication date

3 September 2013

1 reference

18 August 2017

1 reference

18 August 2017

8

1 reference

18 August 2017

9

1 reference

18 August 2017

e73154

1 reference

Creative Commons Attribution 4.0 International

18 August 2017

start time

3 September 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3760909

Beta-cell function assessment from modelling of oral tests: an effective approach

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3760909

The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3760909

Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3760909

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3760909

Glucose clamp technique: a method for quantifying insulin secretion and resistance

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3760909

Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients

21 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073154

Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073154

Impaired regulation of the incretin effect in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073154

Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073154

Characterization of GLP-1 effects on beta-cell function after meal ingestion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073154

Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073154

Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073154

Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073154

Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073154

A model-based method for assessing insulin sensitivity from the oral glucose tolerance test

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073154

Improved tolerance to sequential glucose loading (Staub-Traugott effect): size and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073154

Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073154

beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073154

The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0073154

Reduced incretin effect in type 2 (non-insulin-dependent) diabetes

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24019903

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24019903

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0073154

1 reference

18 August 2017

0 references

1 reference

PMC publication ID

3760909

18 August 2017

PubMed publication ID

24019903

1 reference

PMC publication ID

3760909